Cyclacel Pharmaceuticals Reports First Quarter 2014 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. AXP
9. ZETA
10. DAL

Go back to Cyclacel Pharmaceuticals Reports First Quarter 2014 Financial Results

Cyclacel Pharmaceuticals, Inc. (CYCC) Posts Q1 Loss of 25c/Share

May 13, 2014 4:44 PM EDT

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) reported Q1 EPS of ($0.25), $0.01 better than the analyst estimate of ($0.26).

"We are pleased to report that we have enrolled our first European patients in our Phase 3 SEAMLESS trial in AML and expect to open approximately 80 European sites,... More